Legal Representation
Attorney
Patrick J. Jennings
USPTO Deadlines
Next Deadline
544 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210615)
Due Date
June 15, 2027
Grace Period Ends
December 15, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 15, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 30, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 30, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 10, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 11, 2021 | OTHE | I | CASE RETURNED TO EXAMINATION | Loading... |
| Feb 11, 2021 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Feb 11, 2021 | PCBG | O | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | Loading... |
| Feb 11, 2021 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Dec 3, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 1, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 1, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 1, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 9, 2020 | TPDR | I | TEAS PETITION TO DIRECTOR RECEIVED | Loading... |
| Jun 2, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 7, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 7, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 18, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 28, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 28, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 27, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 27, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 5, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 5, 2019 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 5, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 7, 2019 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Sep 25, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 28, 2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Feb 28, 2019 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Feb 28, 2019 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jan 8, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 7, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 7, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 15, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 15, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 15, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 14, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 11, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 2, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Scientific and technological services, namely, research and design in the field of medicine and health in the field of autoimmune diseases and different types of cancer; Design and development of software and databases in the field of autoimmune diseases and different types of cancer; Medical research in the field of autoimmune diseases and different types of cancer; Biological research in the field of autoimmune diseases and different types of cancer; Biotechnology research in the field of autoimmune diseases and different types of cancer; Pharmaceutical research services in the field of autoimmune diseases and different types of cancer; Clinical research in the field of autoimmune diseases and different types of cancer; Research and development services in the field of immunology in the field of autoimmune diseases and different types of cancer; Research and development in the field of microorganisms, cells and antibodies in the field of autoimmune diseases and different types of cancer; Research and development of vaccines and medicines in the field of autoimmune diseases and different types of cancer; Biological analysis in the field of autoimmune diseases and different types of cancer; Biological laboratory services in the field of autoimmune diseases and different types of cancer; Consultancy relating to research and development in the field of therapy; Laboratory services relating to the production of monoclonal antibodies in the field of autoimmune diseases and different types of cancer; Research and development services in the field of antibodies in the field of autoimmune diseases and different types of cancer
Class 044
Medical services in the field of autoimmune diseases and different types of cancer; Advice relating to immunology in the field of autoimmune diseases and different types of cancer; therapy services in the nature of therapeutic health care services in the field of autoimmune diseases and different types of cancer
Classification
International Classes
042
044